LivePerson (LPSN)

9.05 +0.30  +3.43%  May 17, 8:00PM
Add to Watchlists Create an Alert

LivePerson R&D Expense Quarterly:

8.17M for Dec. 31, 2012
View Full Chart

LivePerson R&D Expense Quarterly Chart

    LivePerson Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 8.17M
    Sept. 30, 2012 8.005M
    June 30, 2012 7.219M
    March 31, 2012 6.657M
    Dec. 31, 2011 5.564M
    Sept. 30, 2011 5.266M
    June 30, 2011 5.016M
    March 31, 2011 4.377M
    Dec. 31, 2010 4.257M
    Sept. 30, 2010 3.94M
    June 30, 2010 3.908M
    March 31, 2010 3.606M
    Dec. 31, 2009 3.162M
    Sept. 30, 2009 3.109M
    June 30, 2009 3.138M
    March 31, 2009 2.701M
    Dec. 31, 2008 3.023M
    Sept. 30, 2008 3.299M
    June 30, 2008 3.503M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    LPSN R&D Expense Quarterly Benchmarks

    Companies
    Birner Dental Management Services
    PRGX Global
    Keynote Systems

    LPSN R&D Expense Quarterly Rankings

    Overall 91st percentile
    661 of 7590
    Sector 92nd percentile
    59 of 799 in Industrials
    Industry 93rd percentile
    12 of 172 in Business Services

    LPSN R&D Expense Quarterly Range, Past 5 Years

    Minimum 2.701M Mar 2009
    Maximum 8.170M Dec 2012
    Average 4.627M